This brand name is authorized in Nigeria.
The drug NORBALOG contains a combination of these active pharmaceutical ingredients (APIs):
1
|
UNII
F446C597KA - TRIAMCINOLONE ACETONIDE
|
|
Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect. |
|
2
|
UNII
H438WYN10E - ECONAZOLE NITRATE
|
|
Econazole nitrate is a broad spectrum antimycotic with activity against dermatophytes, yeasts and moulds. A clinically relevant action against Gram positive bacteria has also been found. |
|
3
|
UNII
8X7386QRLV - GENTAMICIN SULFATE
|
|
Gentamicin is usually bactericidal in action. Although the exact mechanism of action has not been fully elucidated, the drug appears to inhibit protein synthesis in susceptible bacteria by irreversibly binding to 30S ribosomal subunits. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| A4-100675 | Cream | Norbalog Cream 30 g (strength format) CREAM 1mg; 10mg; 1mg 1 x 30 g (in Lami tube) | Topical Cream White colored homogenous cream 21 NF-PP-339165 NORBALOG CREAM 30GM TRIAMCINOLONE ACETONIDE BP 1MG, ECONAZOLE NITRATE BP 10MG, GENTAMYCIN SULPHATE BP 1MG TRIAMCINOLONE ACETONIDE BP 1MG, ECONAZOLE NITRATE BP 10MG, GENTAMYCIN SULPHATE BP 1MG A4-100675 Drugs Imported Products 130GM OTC 7/3/2023 NORBARC PHARMACEUTICAL LIMITED, NO. 7 ABEOKUTA STREET EBUTE META 7036535830 norbarcpharm@yahoo.com MARINE LIFE SCIENCES., PLOT NO.30 PHASE III (EXT) HPSIDC, BADDI DSTT. SOLAN (H.P) INDIA, India | 21/12/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| D07CB01 | Triamcinolone and antibiotics | D Dermatologicals → D07 Corticosteroids, dermatological preparations → D07C Corticosteroids, combinations with antibiotics → D07CB Corticosteroids, moderately potent, combinations with antibiotics |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | A4-100675 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.